Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Ion Beam Applications's Enterprise Value is €523.8 Mil.
Ion Beam Applications's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €-25.7 Mil. Therefore, Ion Beam Applications's EV-to-OCF for today is -20.41.
The historical rank and industry rank for Ion Beam Applications's EV-to-OCF or its related term are showing as below:
FRA:IOB'
s EV-to-OCF Range Over the Past 10 Years
Min: -95.01 Med: -12.89 Max: 27.98
Current: -20.41
During the past 13 years, the highest EV-to-OCF of Ion Beam Applications was 27.98. The lowest was -95.01. And the median was -12.89.
FRA:IOB's EV-to-OCF is ranked better than 87.34% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.85
vs FRA:IOB: -20.41
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ion Beam Applications (FRA:IOB) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ion Beam Applications's PE Ratio (TTM) for today is calculated as:
Ion Beam Applications's share price for today is €15.86.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ion Beam Applications's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.420.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ion Beam Applications's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's EV-to-OCF falls into.
Ion Beam Applications's current Enterprise Value is €523.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ion Beam Applications's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €-25.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ion Beam Applications (FRA:IOB) has a EV-to-OCF of -20.41 as of Aug. 10, 2026. According to the industry distribution chart, Ion Beam Applications ranks #108 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 12.7%.
Is Ion Beam Applications' EV-to-OCF too high?
Ion Beam Applications' current EV-to-OCF is -20.41. Based on the distribution chart, Ion Beam Applications ranks #108 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ion Beam Applications has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #108 out of 853 companies for EV-to-OCF. This places Ion Beam Applications in the top 13% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 7.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.85, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current EV-to-OCF is -20.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (FRA:IOB) is currently considered Fairly Valued. The stock's GF Value™ is €15.77, compared to a current price of €15.86 — trading 0.6% above its estimated fair value. The current EV-to-OCF is -20.41. Ion Beam Applications' overall GF Score™ is 85/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Ion Beam Applications (FRA:IOB), the current EV-to-OCF is -20.41 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (FRA:IOB) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be overvalued.
The current stock price of €15.86 is trading 0.6% above its estimated GF Value™ of €15.77.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for FRA:IOB:
EV-to-OCF: -20.41
GF Value™: €15.77 vs. price of €15.86 (0.6% above fair value)
No single metric tells the full story. See the FRA:IOB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
85GF Score
Get the complete analysis for FRA:IOB
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IOB has been successfully added to your 
